热门
An oncolytic adenoviral vector of smac increases antitumor activity of TRAIL against HCC in human cells and in mice
文献类型：期刊论文
| 作者 | Pei, ZF; Chu, L; Zou, WG; Zhang, ZL; Qiu, SB; Qi, R; Gu, JF; Qian, C; Liu, XY |
| 刊名 | HEPATOLOGY
 |
| 出版日期 | 2004 |
| 卷号 | 39期号:5页码:1371-1381 |
| 通讯作者 | Liu, XY (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.,xyliu@sibs.ac.cnor |
| 英文摘要 | Hepatocellular carcinoma (HCC) displays a high resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell death. To increase sensitivity of HCC cells to TRAIL, we have constructed an oncolytic adenoviral vector (ZD55) and used this vector to deliver second mitochondria-derived activator of caspases (Smac) and TRAIL genes (ZD55-Smac and ZD55-TRAIL respectively) into HCC cells. Our data showed that human HCC cells express high levels of inhibitor of apoptosis proteins (IAPs). Transfected HCC cells expressing exogenous X-linked IAPs (XIAPs) displayed more resistance to TRAIL The expression of Smac led to rapid and potent activation of apoptosis in HCC cells after infection with ZD55-Smac. The activation of caspases and induction of apoptosis could be enhanced further through coinfection with ZD55-TRAIL The combined treatment of ZD55-Smac and ZD55-TRAIL resulted in significant reduction of XIAP expression levels. In addition, our in vivo data in mice showed only a partial response in the established tumor treated either by ZD55-Smac or ZD55-TRAIL alone. By contrast, complete tumor regression was observed by combination of ZD55-Smac and ZD55-TRAIL in all treated animals. This strong antitumoral activity achieved by this combination was due to a dramatic induction of tumor cell apoptosis in the treated tumors. In conclusion, our data indicate that Smac antagonizes the IAPs in HCC tumor cells and enhances tumor cell death induced by TRAIL in the oncolytic adenoviral vector. The combination of Smac and TRAIL delivered by way of the oncolytic adenoviral vector would provide a useful strategy for therapy of HCC and might also be applied to other IAPs abundant in cancers. |
| 学科主题 | Gastroenterology & Hepatology |
| 类目[WOS] | Gastroenterology & Hepatology |
| 关键词[WOS] | REPLICATION-COMPETENT ADENOVIRUS ; MITOCHONDRIA-DERIVED ACTIVATOR ; DOUBLE SUICIDE GENE ; X-LINKED INHIBITOR ; HEPATOCELLULAR-CARCINOMA ; INDUCED APOPTOSIS ; MEDIATED APOPTOSIS ; CASPASE ACTIVITY ; STRUCTURAL BASIS ; FAMILY PROTEINS |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000221050100023 |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.143/handle/331003/2090]  |
| 专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
| 推荐引用方式 GB/T 7714 | Pei, ZF,Chu, L,Zou, WG,et al. An oncolytic adenoviral vector of smac increases antitumor activity of TRAIL against HCC in human cells and in mice[J]. HEPATOLOGY,2004,39(5):1371-1381. |
| APA | Pei, ZF.,Chu, L.,Zou, WG.,Zhang, ZL.,Qiu, SB.,...&Liu, XY.(2004).An oncolytic adenoviral vector of smac increases antitumor activity of TRAIL against HCC in human cells and in mice.HEPATOLOGY,39(5),1371-1381. |
| MLA | Pei, ZF,et al."An oncolytic adenoviral vector of smac increases antitumor activity of TRAIL against HCC in human cells and in mice".HEPATOLOGY 39.5(2004):1371-1381. |
入库方式： OAI收割
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。